Abstract
Encapsulated hepatocyte transplantation and encapsulated mesenchymal stem cell transplantation are newly developed potential treatments for acute and chronic liver diseases, respectively. Cells are microencapsulated in biocompatible semipermeable alginate-based hydrogels. Microspheres protect cells against antibodies and immune cells, while allowing nutrients, small/medium size proteins and drugs to diffuse inside and outside the polymer matrix. Microencapsulated cells are assessed in vitro and designed for experimental transplantation and for future clinical applications.
Here, we describe the protocol for microencapsulation of hepatocytes and mesenchymal stem cells within hybrid poly(ethylene glycol)-alginate hydrogels.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meier RP, Navarro-Alvarez N, Morel P et al (2015) Current status of hepatocyte xenotransplantation. Int J Surg 23:273–279
Rokstad AM, Brekke OL, Steinkjer B et al (2011) Alginate microbeads are complement compatible, in contrast to polycation containing microcapsules, as revealed in a human whole blood model. Acta Biomater 7:2566–2578
Rokstad AM, Brekke OL, Steinkjer B et al (2013) The induction of cytokines by polycation containing microspheres by a complement dependent mechanism. Biomaterials 34:621–630
Meier RP, Seebach JD, Morel P et al (2014) Survival of free and encapsulated human and rat islet xenografts transplanted into the mouse bone marrow. PLoS One 9:e91268
Lavallard V, Armanet M, Parnaud G et al (2015) Cell rearrangement in transplanted human islets. FASEB J 30:748–760
Mahou R, Meier R, Bühler L et al (2014) Alginate-poly(ethylene glycol) hybrid microspheres for primary cell microencapsulation. Materials 7:275–286
Mahou R, Wandrey C (2010) Alginate-poly(ethylene glycol) hybrid microspheres with adjustable physical properties. Macromolecules 43:1371–1378
Mahou R, Kolláriková G, Gonelle-Gispert C et al (2013) Combined electrostatic and covalent polymer networks for cell microencapsulation. Macromolecular Symposia 329:49–57
Mei J, Sgroi A, Mai G et al (2009) Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Cell Transplant 18:101–110
Sgroi A, Mai G, Morel P et al (2011) Transplantation of encapsulated hepatocytes during acute liver failure improves survival without stimulating native liver regeneration. Cell Transplant 20:1791–1803
Meier RP, Mahou R, Morel P et al (2015) Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice. J Hepatol 62:634–641
Meier RP, Muller YD, Morel P et al (2013) Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res 11:1348–1364
Hengstler JG, Brulport M, Schormann W et al (2005) Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 1:61–74
Acknowledgments
This work was supported by Swiss National Science Foundation (SNSF) grant 205322 130572/1 and 205321 141286/1, the Insuleman Foundation, the Foundation Privée des HUG, and the Geneva University Hospital and Medical School.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media New York
About this protocol
Cite this protocol
Meier, R.P.H. et al. (2017). Microencapsulation of Hepatocytes and Mesenchymal Stem Cells for Therapeutic Applications. In: Stock, P., Christ, B. (eds) Hepatocyte Transplantation. Methods in Molecular Biology, vol 1506. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6506-9_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6506-9_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6504-5
Online ISBN: 978-1-4939-6506-9
eBook Packages: Springer Protocols